Yousef Zakharia, Medical Oncologist and Vice-Chair of the Genitourinary Malignancy Disease Group at the Mayo Clinic Comprehensive Cancer Center, shared a post on X by Mehndi Dandwani, Haematology-oncology Fellow at the University of Iowa Health Care, adding:
“Was great chatting with Raquibul Hannan and Chad Tang about the role of RT in RCC through VIRO 2025.
An effective tool to be utilized in clinic. Thanks for summarizing Mehndi Dandwani.”
Quoting Mehndi Dandwani’s post below:
“Size doesn’t matter as much as location for SBRT
- Radiation stimulates Ag presentation
- Fractionated approach favored >8cm
- 10-15 ml/min decline in eGFR
- TKIs with radiation, hold at least for 2.5.”
Read Further: Highlights from Day 2 of VIRO 2025: Charting the Future of Renal Oncology on the Final Day.